diflomotecan has been researched along with sn 38 in 1 studies
| Studies (diflomotecan) | Trials (diflomotecan) | Recent Studies (post-2010) (diflomotecan) | Studies (sn 38) | Trials (sn 38) | Recent Studies (post-2010) (sn 38) |
|---|---|---|---|---|---|
| 17 | 4 | 3 | 85 | 1 | 43 |
| Protein | Taxonomy | diflomotecan (IC50) | sn 38 (IC50) |
|---|---|---|---|
| DNA topoisomerase 1 | Homo sapiens (human) | 3.25 | |
| DNA topoisomerase 1 | Mus musculus (house mouse) | 4 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.176 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Q; Lu, W; Wang, L | 1 |
1 review(s) available for diflomotecan and sn 38
| Article | Year |
|---|---|
Evolution in medicinal chemistry of E-ring-modified Camptothecin analogs as anticancer agents.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2013 |